Details for Patent: 12,257,246
Which drugs does patent 12,257,246 protect, and when does it expire?
Patent 12,257,246 protects REYVOW and is included in one NDA.
This patent has forty-five patent family members in twenty-five countries.
Summary for Patent: 12,257,246
| Title: | Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl[-benzamide |
| Abstract: | The present invention relates to discloses a pharmaceutical composition of 2,4,6-trifluoro-N-[6-(1-methyl-piperidin-4-ylcarbonyl)-pyridin-2-yl]-benzamide and a pharmaceutically acceptable carrier. |
| Inventor(s): | Alison Pilgrim, James F. White, Nadia M. J. Rupniak |
| Assignee: | Colucid Pharmaceuticals Inc |
| Application Number: | US17/474,203 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Dosage form; |
Drugs Protected by US Patent 12,257,246
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly And Co | REYVOW | lasmiditan succinate | TABLET;ORAL | 211280-001 | Jan 31, 2020 | DISCN | Yes | No | 12,257,246 | ⤷ Start Trial | ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS | ⤷ Start Trial | ||||
| Eli Lilly And Co | REYVOW | lasmiditan succinate | TABLET;ORAL | 211280-002 | Jan 31, 2020 | DISCN | Yes | No | 12,257,246 | ⤷ Start Trial | ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS | ⤷ Start Trial | ||||
| Eli Lilly And Co | REYVOW | lasmiditan succinate | TABLET;ORAL | 211280-003 | Dec 18, 2020 | DISCN | Yes | No | 12,257,246 | ⤷ Start Trial | ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,257,246
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2413933 | ⤷ Start Trial | PA2023502 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2413933 | ⤷ Start Trial | 301214 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2413933 | ⤷ Start Trial | CA 2023 00001 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
